SNTI (Senti Biosciences, Inc.) Earnings per share growth rate in current year

Corporate emblem and logo of Senti Biosciences, Inc. (SNTI)

Senti Biosciences, Inc. (SNTI) strictly adheres to biosafety standards during the disposal of biomaterials. Business development relies on the clinical testing schedule, ignoring economic cycles. The annual change in earnings per share reflects the impact of "smart" gene circuits and successes in leukemia treatment, where 0.00 determines this parameter level.

SNTI: Senti Bio Earnings per share growth in current year 04/28/2023 - 11/14/2026

Financial and market metric breakdowns for sentibio.com (SNTI)

- price and consensus price forecast:
Stock Quotes Senti Biosciences|SNTI - Analyst Consensus Forecast
- business market valuation indicators:
Market Value SNTI|SNTI - Total Company Value
- balance sheet equity data:
Net Assets per Single Share Senti Biosciences|SNTI - Company Book Value|Market Value to Book Value Ratio sentibio.com|SNTI - Cumulative Company Assets
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Senti Biosciences, Inc.|SNTI - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Senti Biosciences|SNTI - Company Aggregate Debts|Debts to Book Value SNTI|SNTI - Company Long-Term Debt|Company Short-Term Indebtedness Senti Biosciences|Immediate Liquidity sentibio.com
- earnings and valuation multiples information:
SNTI - Net Income|Expected Net Income Senti Biosciences, Inc.|SNTI - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Senti Biosciences|SNTI - PEG Multiple|Business Value to Operating Income Before Depreciation SNTI|SNTI - Operating profit EBITDA|Net earnings per one share for the last twelve months Senti Biosciences|SNTI - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months sentibio.com|SNTI - Earnings growth in current year|Earnings growth forecast for next year Senti Biosciences, Inc.
- revenue and sales proceeds data:
SNTI - Company Revenue|Company Expected Revenue Senti Biosciences|SNTI - Market Cap to Revenue|Market Cap to Future Revenue Ratio SNTI
Fundamental valuation:SNTI Senti Biosciences Inc
Manufactured products of Senti Biosciences

This indicator is calculated as the percentage deviation of current earnings per share from the same value last year. The metric determines the dynamics of net yield, allowing for an assessment of business stability without accounting lags. For Senti Biosciences, Inc. (SNTI), the value 0.00 reflects the financial burden of the development stage for genetic circuits used in targeted cancer therapy. Investors should analyze the proportional growth of EPS compared to last year to evaluate the pace of commercialization in synthetic biology. Such monitoring minimizes the risks of unexpected portfolio drawdowns.

Main competitors

Net earnings per share growth this year Legend Biotech Corp|SANA (Sana Bio) - Earnings growth in current year|Earnings per share growth rate in current year Autolus Corp AUTL|Earnings per share growth in current year Allogene Therapeutics (ALLO)|Earnings per share growth in current year RNAC (selectabio.com)|Earnings per share growth in current year Cellectis CLLS|Caribou Biosciences Inc. - Earnings per share growth in current year|TIL: Net earnings per share growth this year|Earnings per share increase in current year GNTA (Genenta Science S.p.A.)|IPSC: Earnings growth in current year|Net earnings per share change in current year Jasper Therapeutics, Inc. JSPR|ADAP (Adaptimmune Therapeutics plc) - Earnings growth in current year|Earnings per share growth rate in current year CERo Therapeutics Holdings Inc. CERO|Earnings per share growth in current year Alaunos Therapeutics (TCRT)|achillestx.com - Earnings per share growth this year|Earnings growth in current year CRGX (CARGO Therapeutics)|poseida.com (PSTX) - Earnings per share growth rate in current year|TSVT: Net earnings per share growth this year|Earnings per share increase in current year GRCL (Gracell Bio)